There is currently not an FDA-approved intracameral antibiotic in the U.S., but there are FDA-approved options for dropless pain and inflammation treatment after cataract surgery, and some surgeons, including three who spoke with EyeWorld, have chosen to employ a dropless approach off-label, based on available safety and efficacy data.
When it comes to true presbyopia-correcting lenses, there are two main categories: extended depth of field and full depth of field. Both of these categories have new additions (at least new to the U.S. market), and surgeons already using these lenses are excited about the results.
Finding the most effective way to approach a patient with glaucoma can be a challenge, and it may take time to find the best treatment or combination of treatments. Three physicians discussed how they are combining medications with procedural intervention and the future of treatments in the glaucoma field.
Karolinne Rocha, MD, PhD, previewed the articles in the Refractive section of the issue, concluding, “As we look to the future, ophthalmology will continue to rewind, looking at where we’ve been, refresh, what we’ve been doing well, and refine, what we can improve, for the betterment of our patients’ vision.”
Chief Medical Editor Mitchell Weikert, MD, highlighted the theme of the issue, summarizing several of the articles, reminded readers of the ASCRS Live! events happening around the country, and closed with an emphasis on the importance of supporting ASCRS advocacy efforts.
There are several all-in-one phacovitrectomy machines on the market that seek to streamline workflows, reduce equipment footprint, and improve efficiency. The decision to invest in a combined system depends on case mix, staffing patterns, and how often vitreous management is needed in the cataract OR. Three physicians weighed in on the topic.
While many surgeons reserve the Light Adjustable Lens (LAL, RxSight) for post-LASIK, post-PRK, and difficult eyes, others are increasingly using it in routine cataract patients, finding that the ability to set refraction postop with patient input offers advantages. Three physicians shared their experiences and perspectives on this.
Blepharitis diagnosis and treatment have shifted in recent years, from the ability to diagnose blepharitis subtypes to the ability to treat those subtypes specifically. Overall, it’s becoming a more treatable ocular surface disease, and three experts had something to say about it.
In a fast-paced session at the 2026 ASCRS Annual Meeting, presenters shared videos and pearls on a variety of glaucoma topics, competing for audience votes in this Survivor-themed symposium. Audience members voted off one speaker per round until there was one remaining survivor on “Temporal Island.” Read the recap here.
The professional life of an ophthalmologist is packed, from clinic days to surgery days to completing charts and more. So how do ophthalmologists find time to work with industry, be that product development, clinical trial involvement, or speaking engagements? Three ophthalmologists provided their perspectives on this and more.
Get the latest ophthalmology news delivered to your inbox every Friday.